Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.

J Immunother Cancer · 2023 · PMC10603353 · PMID 37865396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Kaplan-Meier survival analysis suggested survival differences found among the two groups, suggesting better survival benefits in the low-risk group, although they did not reach statistical significance ( online supplemental figure S7 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.